NovoCure Limited
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2013 | $-52.7M | $-54.9M | $2.2M | $5.1M |
| FY2014 | $-74.2M | $-75.1M | $849.0K | $4.6M |
| FY2015 | $-99.9M | $-104.6M | $4.7M | $11.9M |
| FY2016 | $-107.6M | $-113.3M | $5.7M | $22.1M |
| FY2017 | $-33.1M | $-40.5M | $7.4M | $27.1M |
| FY2018 | $-1.9M | $-8.6M | $6.7M | $39.8M |
| FY2019 | $26.6M | $16.1M | $10.5M | $52.4M |
| FY2020 | $99.1M | $84.2M | $15.0M | $75.7M |
| FY2021 | $82.8M | $58.6M | $24.2M | $94.9M |
| FY2022 | $30.8M | $9.4M | $21.4M | $107.0M |
| FY2023 | $-73.3M | $-100.4M | $27.1M | $115.6M |
| FY2024 | $-26.4M | $-69.2M | $42.9M | $160.0M |
| FY2025 | $-49.0M | $-75.7M | $26.6M | $104.8M |